Skip to main content

Cell Line Development Market to Surpass Market Valuation of USD 15.88 Billion by 2031 | SkyQuest Technology

Written by Customer Service on . Posted in Mergers And Acquisitions.

Growing at a CAGR of 9.84% during the forecast period (2024-2031).

Westford, USA, Nov. 13, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Cell Line Development Market will reach a value of USD 15.88 Billion by 2031, with a CAGR of 12.12% during the forecast period (2024-2031). Cell line development, or CLD, will likely become popular as more and more biopharmaceutical companies start sprouting up. Cells are used as an expression host by most biopharma companies to synthesise recombinant monoclonal antibodies and proteins. The market is expected to grow in the upcoming years due to the availability of improved technologies for producing novel cell lines, as well as an increase in demand for cancer medicines and monoclonal antibodies.

Download a detailed overview:
https://www.skyquestt.com/sample-request/cell-line-development-market

Cell Line Development Market Overview:

Report Coverage  Details 
Market Revenue in 2023  USD 6.36 Billion 
Estimated Value by 2031  USD 15.88 Billion 
Growth Rate  Poised to grow at a CAGR of 12.12% 
Forecast Period  2024–2031 
Forecast Units  Value (USD Billion) 
Report Coverage  Revenue Forecast, Competitive Landscape, Growth Factors, and Trends 
Segments Covered  Product, Source, Type of Cell Line, Application and Region 
Geographies Covered  North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa 
Report Highlights  Development and commercialization of biogenerics and biosimilars
Key Market Opportunities  Favorable government support
Key Market Drivers  Growing prevalence of chronic diseases

Reagents and Media to Hold Significant Growth due to Critical Role in Maintaining Cell Health

In global cell line development market, reagents and media products lead due to their crucial role in maintaining cell health, enhancing growth conditions and increasing production of biopharmaceuticals. Rising demand for biologics as well as advances in cell culture techniques are fueling market growth with escalating needs for quality reagents.

Recombinant Cell Lines to Lead the Market due to Consistent Therapeutic Proteins for Biopharmaceutical Applications

The production of uniform, high-yield therapeutic proteins for biopharmaceutical uses has made recombinant cell lines the industry leader in cell line development globally. Efficient recombinant systems are deemed necessary to enable market expansion through improved stability, scalability, and cost-effectiveness in medication manufacture, which is made possible by the growing need for biosimilars and monoclonal antibodies.

North America to Dominate the Market Due to Strong Biopharmaceutical R&D

Rich in biopharmaceutical R&D, sophisticated healthcare infrastructure, and substantial biotechnology investment, North America dominates the global cell line development market. A well-established pharmaceutical industry, favourable regulatory frameworks, and the region’s expertise in drug research and development fuel demand for cutting-edge cell line creation technology.

Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/cell-line-development-market

Cell Line Development Market Insight

Drivers:

  1. Rising Demand for Biologics
  2. Growth in Biopharmaceutical R&D
  3. Expansion of Contract Research Organizations (CROs)

Restraints:

  1. Risk of Contamination
  2. Intellectual Property Issues
  3. Limited Cell Line Diversity

Prominent Players in Cell Line Development Market
The following are the Top Cell Line Development Companies:

  • Thermo Fisher Scientific (USA)
  • Lonza Group (Switzerland)
  • Merck KGaA (Germany)
  • Sartorius AG (Germany)
  • GE Healthcare (USA)
  • WuXi AppTec (China)
  • Danaher Corporation (USA)
  • Selexis SA (Switzerland)
  • Sigma-Aldrich (USA)
  • Corning Incorporated (USA)

View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/cell-line-development-market

 Key Questions Answered in Global Cell Line Development Market Report

  • What is the estimated market size for cell line development globally by 2031, and what is the anticipated compound annual growth rate (CAGR) for the 2024–2031 projection period?
  • Why do media and reagent goods command such a strong market share in the global cell line development industry?
  • Which geographical region leads the global cell line development market, and what elements support this dominance?

This report provides the following insights:

  • Analysis of key drivers (Increasing demand for biologic drugs, need for robust cell line development, innovations in cell culture techniques), restraints (Developing stable cell lines, regulatory approvals for cell line-based therapies, small number of standardized cell lines), opportunities (Producing viral vectors, growing interest in gene therapy, AI-driven tools for optimizing cell line development workflows), and challenges (Public concerns about the use of GMOs, maintaining CLD product consistency & quality) influencing the growth of cell line development market.
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the cell line development market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the cell line development market
  • Market Development: Comprehensive information on lucrative emerging regions
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

Related Reports:

  1.  Digital Health Market is growing at a CAGR of 18.6% over the forecast period (2024–2031).  
  1.  Digital Therapeutics Market is growing at a CAGR of 16.61% during the forecast period (2024-2031).
  1.  Biosimilars Market is growing at a CAGR of 16.4% over the forecast period (2024-2031).  
  1.  Regenerative Medicine Market is growing at a CAGR of 27.2% in the forecast period (2024-2031).
  1.  3D Cell Culture Market is growing at a CAGR of 18.2% during the forecast period (2024-2031). 

 

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.